Goldman Sachs’s Unicycive Therapeutics UNCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,348
| Closed | -$42.2K | – | 5377 |
|
|
2025
Q1 | $42.2K | Sell |
7,348
-13
| -0.2% | -$75 | ﹤0.01% | 4937 |
|
|
2024
Q4 | $58.5K | Sell |
7,361
-1,981
| -21% | -$15.7K | ﹤0.01% | 4847 |
|
|
2024
Q3 | $38.1K | Buy |
9,342
+7
| +0.1% | +$29 | ﹤0.01% | 4679 |
|
|
2024
Q2 | $46.8K | Buy |
9,335
+1
| +0% | +$5 | ﹤0.01% | 4570 |
|
|
2024
Q1 | $129K | Hold |
9,334
| – | – | ﹤0.01% | 4415 |
|
|
2023
Q4 | $81K | Buy |
9,334
+11
| +0.1% | +$95 | ﹤0.01% | 4494 |
|
|
2023
Q3 | $80.2K | Sell |
9,323
-270
| -3% | -$2.32K | ﹤0.01% | 4427 |
|
|
2023
Q2 | $123K | Buy |
+9,593
| New | +$123K | ﹤0.01% | 4530 |
|